Related Experiment Video
Updated: Aug 12, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
[Wearable defibrillator : Current evidence]
David Duncker1, Christian Veltmann2
1Rhythmologie und Elektrophysiologie, Klinik für Kardiologie und Angiologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland. duncker.david@mh-hannover.de.
Insights
The wearable cardioverter-defibrillator (WCD) is safe and effective for preventing sudden cardiac death, especially in patients with cardiomyopathy. Proper patient selection and management are key to its successful use.
Area of Science:
- Cardiology
- Medical Devices
Background:
- Wearable cardioverter-defibrillators (WCDs) are increasingly used for sudden cardiac death prevention.
- Clinical registries show extensive use, with nearly 40,000 patients documented.
Purpose of the Study:
- To review current data and recommendations for WCD use.
- To highlight the role of WCDs in specific patient populations.
Main Methods:
- Review of published clinical registries and one randomized study.
- Analysis of WCD safety and efficacy data.
Main Results:
- WCDs are safe and effective in preventing sudden cardiac death.
- Patients with newly diagnosed cardiomyopathy and reduced left ventricular function benefit significantly.
- WCDs provide protection during heart failure medication optimization in patients without ICD indications.
Conclusions:
- WCDs are integrated into clinical practice and guidelines.
- Careful patient selection and structured management are essential for optimal WCD prescription.
- WCDs offer a valuable non-implantable option for managing arrhythmia risk.
Abstract:
The wearable cardioverter/defibrillator (WCD) is safe and effective in the prevention of sudden cardiac death, and has found its way into international guidelines and clinical practice. Nearly 40,000 patients with a WCD have been published in clinical registries and one randomized study has recently been presented. Especially patients with newly diagnosed cardiomyopathy with severely reduced left ventricular function show an increased risk for ventricular tachyarrhythmias and may benefit from a WCD. In these patients without an indication for an implantable cardioverter-defibrillator (ICD), the WCD offers protection from sudden cardiac death during initiation and optimization of heart failure medication. Critical patient selection and structured patient management is crucial for successful WCD prescription. This review gives an overview of the current data and recommendations on WCD.
Related Concept Videos
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Holter Monitor: 24-Hour Monitoring
Dysrhythmias V: Evaluating Dysrhythmias
Cardiopulmonary Resuscitation III: AED Use
Cardiopulmonary Resuscitation IV: Pharmacological Management

